share_log

Piper Sandler Maintains Overweight on Minerva Surgical, Lowers Price Target to $5

Benzinga Real-time News ·  Aug 10, 2022 07:08

Piper Sandler analyst Matt O'Brien maintains Minerva Surgical (NASDAQ:UTRS) with a Overweight and lowers the price target from $6 to $5.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment